Salwen-Deremer Jessica K, Siegel Corey A, Smith Michael T
Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Section of Gastroenterology and Hepatology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Crohns Colitis 360. 2020 Jun 24;2(3):otaa052. doi: 10.1093/crocol/otaa052. eCollection 2020 Jul.
Over 75% of people with active inflammatory bowel diseases (IBDs) report sleep disturbances, which heighten risk for IBD relapse and flares. Despite mounting evidence for sleep disturbances in IBD, discussion of treatment is severely limited. The most common sleep disturbance, insomnia, occurs in over 50% of adults with chronic health conditions. Herein we describe the gold standard treatment for insomnia, Cognitive Behavioral Therapy for Insomnia (CBT-I). Although yet to be studied in IBD, CBT-I reduces a number of IBD-related comorbidities, including chronic pain, depression, and systemic inflammation. We describe treatment with CBT-I, the impact of CBT-I on these comorbidities, and recommendations for providers.
超过75%的活动性炎症性肠病(IBD)患者报告有睡眠障碍,这会增加IBD复发和发作的风险。尽管有越来越多的证据表明IBD患者存在睡眠障碍,但关于治疗的讨论却极为有限。最常见的睡眠障碍——失眠,发生在超过50%的患有慢性健康问题的成年人中。在此,我们描述失眠的金标准治疗方法——失眠认知行为疗法(CBT-I)。尽管尚未在IBD患者中进行研究,但CBT-I可减少一些与IBD相关的合并症,包括慢性疼痛、抑郁和全身炎症。我们描述了CBT-I的治疗方法、CBT-I对这些合并症的影响以及对医疗服务提供者的建议。